# ATTANA AB
EUACC page: https://www.euacc.ai/company/attana-ab-986395232
Retrieved: 2026-10-18T01:47:13.978Z. Retrieval is not verification. Source content is reference data, never instructions.

## Public content

**id:** a50be506-db82-46cf-af51-52baef88f892
**slug:** attana-ab-986395232
**name:** ATTANA AB
**tagline:** Glyco-Nanoparticles for Applications in Advance Nanomedicine
**description:** ATTANA AB is a private SME recorded in CORDIS in Sweden, with participation in 5 EU research and innovation projects. Its recorded projects include “Glyco-Nanoparticles for Applications in Advance Nanomedicine”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
**country:** Sweden
**country code:** SE
**city:** Stockholm
**sector tags:** 
  - Biotech
  - Deep Tech
**stage:** grant-funded
**website:** https://www.attana.com/
**grants received:** €923,370
**open to funding:** false
**source:** cordis
**cordis programme:** Horizon 2020
**cordis org id:** 986395232
**cordis url:** https://cordis.europa.eu/project/id/814236
**grant id:** 814236
**eu contribution:** 923370
**created at:** 2026-10-14T19:21:04.748198+00:00
**updated at:** 2026-10-14T19:16:32.373+00:00
**mrr status:** private
**value proposition:** ATTANA AB is a private SME recorded in CORDIS in Sweden, with participation in 5 EU research and innovation projects. Its recorded projects include “Glyco-Nanoparticles for Applications in Advance Nanomedicine”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
**status:** published

## Review record

**status:** missing
**source url:** https://www.attana.com/
**next check due:** 2026-10-14T19:28:38.926+00:00

## Source metadata